North Dakota House · 2025 Regular Session

HB 1543: AN ACT to provide for a legislative management study regarding prescription drug pricing and the maximum fair price as determined by the federal government

Final Passage (Concurrence) · March 18, 2025 · Yeas 89, nays 4

How each party voted

Democrats
Yea 11 · Nay 0
Republicans
Yea 78 · Nay 4 · Not voting 1

Speaker Robin Weisz voted yea.

Bill

Bill
HB 1543
Motion
Final Passage (Concurrence)
Date
March 18, 2025, 13:49
Session
2025 Regular Session
Yeas–nays
Yeas 89, nays 4; 1 didn't vote (0 excused, 0 abstained)
Result
Passed, as the official record marks it

Official record: the Journal's page ↗
The bill's page on the Legislative Assembly's site ↗

The chamber on this vote

Seats are today's members, liberal to conservative; members who have left aren't shown.

← Most liberalThe aisleMost conservative →

How each member voted

Yea (89)

Nay (4)

Not voting (1)